Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term “inflammatory pathway in skin wound” does not designate a single molecule, receptor, or protein, but rather refers collectively to the **complex and coordinated series of molecular, cellular, and biochemical events** that mediate the inflammation phase of skin wound healing. This process is initiated after tissue injury and hemostasis, primarily involving **activation of innate immune cells** (such as neutrophils, macrophages, mast cells, and dendritic cells), **release of damage- and pathogen-associated molecular patterns** (DAMPs and PAMPs), and **production of pro-inflammatory cytokines** and chemokines (including TNF-α, IL-1β, IL-6, CCL2, etc)[1][2][3][4][5]. Critical molecular players include **NF-κB signaling**, selectins, integrins, and various prostaglandins and leukotrienes. Inflammatory mediators act on endothelial cells to promote vasodilation and increased permeability, facilitate immune cell recruitment, and trigger local cell activation for debridement and microbial clearance. Overactivation or prolongation of these events can contribute to **chronic wounds and fibrosis**, making several inflammation-related molecules potential therapeutic targets[5][6][7]. However, “inflammatory pathway in skin wound” itself is not a single canonical target, but a network of pathways and mediators. Note: - There is something incorrect about this entry: it is not a molecular target or receptor but an entire biological process or set of signaling pathways. It cannot be uniquely mapped to a single gene/protein and does not fit therapeutic target conventions. - For structured data, consider specifying individual molecular targets (e.g., “Tumor necrosis factor-alpha”, “Interleukin-1 beta”, “NLRP3 inflammasome”, “NF-κB”) if you need clear linkage to drugs or therapeutic interventions.
Inhibition of pro-inflammatory cytokine production, Blockade of cytokine receptors, Suppression of immune cell recruitment, Reduction of oxidative stress
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inflammatory pathway in skin wound.